MDA (TSE:MDA) Price Target Cut to C$15.00

MDA (TSE:MDAGet Rating) had its target price lowered by Canaccord Genuity Group from C$20.00 to C$15.00 in a note issued to investors on Thursday, BayStreet.CA reports.

Several other equities research analysts have also commented on MDA. Royal Bank of Canada upped their price target on MDA from C$13.00 to C$15.00 and gave the stock an “outperform” rating in a research note on Friday, March 18th. BMO Capital Markets dropped their price target on MDA from C$16.50 to C$13.00 in a research note on Friday, March 18th. Finally, Scotiabank dropped their price target on MDA from C$21.00 to C$20.00 in a research note on Friday, March 18th.

The firm has a market capitalization of C$1.10 billion and a price-to-earnings ratio of 462.00. The firm has a 50 day simple moving average of C$9.72 and a two-hundred day simple moving average of C$11.30. MDA has a 12 month low of C$8.06 and a 12 month high of C$16.80. The company has a debt-to-equity ratio of 16.68, a current ratio of 1.30 and a quick ratio of 1.21.

MDA (TSE:MDAGet Rating) last released its earnings results on Tuesday, February 22nd. The company reported C$0.38 EPS for the quarter, beating the consensus estimate of C$0.08 by C$0.30. The business had revenue of C$590.03 million during the quarter, compared to analyst estimates of C$583.97 million. As a group, equities research analysts forecast that MDA will post 0.43 EPS for the current fiscal year.

MDA Company Profile (Get Rating)

MDA Ltd. designs, manufactures, and services space robotics, satellite systems and components, and intelligence systems in Canada, the United States, Europe, Asia, the Middle East, and internationally. It offers geointelligence solutions that provide satellite-generated imagery and analytic services to deliver critical and value-added insights in the areas of national security, climate change monitoring, and maritime surveillance.

Recommended Stories

Receive News & Ratings for MDA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MDA and related companies with's FREE daily email newsletter.